OpenLegislation

Schedule 33A Transitional provision in relation to EU ExitF1

  1. 1Interpretation
  2. 2Manufacturing, wholesale dealing and brokering
  3. 3Transitional provision in respect of conversion of EU marketing authorisations in force immediately before IP completion day
  4. 4Transitional provision in respect of UK marketing authorisations, parallel import licences and parallel distribution notices
  5. 5Transitional provision in relation to variations of marketing authorisations other than converted EU marketing authorisations
  6. 6Transitional provision in relation to the Paediatric Regulation
  7. 8Transitional provision in respect of homoeopathic medicinal products
  8. 9Transitional provision in respect of traditional herbal registrations
  9. 10Transitional provision in respect of pharmacovigilance
  10. 11Transitional provision in respect of Part 12
  11. 12General provision in relation to transitional provisions

Annotations

Textual amendments

F1

Sch. 33A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 7 (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 193); 2020 c. 1, Sch. 5 para. 1(1)